Page last updated: 2024-08-23

ioxitalamic acid and Neoplasms

ioxitalamic acid has been researched along with Neoplasms in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andersen, F; Berthelsen, AK; Holm, S; Højgaard, L; Klausen, TL; Loft, A	1
Adam, JF; Balosso, J; Biston, MC; Charvet, AM; Corde, S; Elleaume, H; Estève, F; Joubert, A; Le Bas, JF	1
Celik, I; Hoppe, M; Ishaque, N; Jungraithmayr, W; Kapp, B; Klose, KJ; Lorenz, W; Schmiedel, E; Sitter, H	1

Trials

2 trial(s) available for ioxitalamic acid and Neoplasms

Article	Year
PET/CT with intravenous contrast can be used for PET attenuation correction in cancer patients. European journal of nuclear medicine and molecular imaging, 2005, Volume: 32, Issue:10 Topics: Adult; Aged; Artifacts; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Injections, Intravenous; Iothalamic Acid; Male; Middle Aged; Neoplasms; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Single-Blind Method; Subtraction Technique; Tomography, X-Ray Computed	2005
Randomised study comparing a non-ionic with an ionic contrast medium in patients with malignancies: first answer with a new diagnostic approach. Inflammation research : official journal of the European Histamine Research Society ... [et al.], 1999, Volume: 48 Suppl 1 Topics: Adult; Anaphylaxis; Blood Pressure; Contrast Media; Double-Blind Method; Electrocardiography; Female; Heart Rate; Histamine Release; Humans; Iothalamic Acid; Male; Neoplasms; Prospective Studies; Radiography	1999

Article

Year

PET/CT with intravenous contrast can be used for PET attenuation correction in cancer patients.

European journal of nuclear medicine and molecular imaging, 2005, Volume: 32, Issue:10

Topics: Adult; Aged; Artifacts; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Injections, Intravenous; Iothalamic Acid; Male; Middle Aged; Neoplasms; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Single-Blind Method; Subtraction Technique; Tomography, X-Ray Computed

2005

Randomised study comparing a non-ionic with an ionic contrast medium in patients with malignancies: first answer with a new diagnostic approach.

Inflammation research : official journal of the European Histamine Research Society ... [et al.], 1999, Volume: 48 Suppl 1

Topics: Adult; Anaphylaxis; Blood Pressure; Contrast Media; Double-Blind Method; Electrocardiography; Female; Heart Rate; Histamine Release; Humans; Iothalamic Acid; Male; Neoplasms; Prospective Studies; Radiography

1999

Other Studies

1 other study(ies) available for ioxitalamic acid and Neoplasms

Article	Year
Sensitivity variation of doped Fricke gel irradiated with monochromatic synchrotron X rays between 33.5 and 80 keV. Radiation protection dosimetry, 2005, Volume: 117, Issue:4 Topics: Barium Sulfate; Calibration; Dose-Response Relationship, Radiation; Gels; Ions; Iothalamic Acid; Magnetic Resonance Spectroscopy; Neoplasms; Radiation Dosage; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Synchrotrons; X-Rays	2005

Article

Year

Sensitivity variation of doped Fricke gel irradiated with monochromatic synchrotron X rays between 33.5 and 80 keV.

Radiation protection dosimetry, 2005, Volume: 117, Issue:4

Topics: Barium Sulfate; Calibration; Dose-Response Relationship, Radiation; Gels; Ions; Iothalamic Acid; Magnetic Resonance Spectroscopy; Neoplasms; Radiation Dosage; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Synchrotrons; X-Rays

2005